The largest database of trusted experimental protocols

3 protocols using ici 182 780

1

Estradiol Signaling and Autophagy Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
DMEM/F12, fetal bovine serum (FBS), penicillin/streptomycin and trypsin/ethylenediaminetetraacetic acid (EDTA) 0.5% were obtained from Invitrogen™ of Brazil (St. Louis, MO, USA). ICI 182,780 (AstraZeneca of Brazil; Cotia, São Paulo, Brazil), 1-[4-(6-bromobenzo[1,3] dioxol-5yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone (G-1; Calbiochem ® ; Merck Biosciences, Darmstadt, Germany), 17β-estradiol 3-benzoate (17β-estradiol, E2) (Sigma Chemical Co.; St Louis, MO, USA) and 4,4’,4’’-(4-propyl-(1H)-pyrazole-1,3,5-triyl) trisphenol (PPT). Rapamycin (RAP) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were obtained from Sigma Aldrich (St. Louis, MO, USA). Acridine orange (AO) was obtained from Molecular Probes (Eugene, OR, USA). The GFP-LC3 plasmid was obtained from the National Institute for Infectious Diseases, USA, and Istituto di Ricovero e Cura a Carattere Scientifico L. Spallanzani , Rome, Italy.
+ Open protocol
+ Expand
2

Investigating EGFR and Androgen Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies for biochemical studies were as follows from Cell Signaling Technology: anti-p-EGFR Tyr 1068 (catalog 2234), anti-p-Akt/PKB (catalog 9271), anti-Akt/PKB (total) (catalog 9272). Anti-p-ERK1/2 Tyr 204 (catalog sc7383), anti-ERK2 (total) (catalog sc154), anti-p53 (catalog sc126), anti-p21 (catalog sc397), anti-p27 (catalog sc528), anti-EGFR antibody for IP (A-10, catalog sc373746), anti-AR (catalog N20) was from Santa Cruz Biotechnology. Anti-cyclin D1 (catalog 33-3500) was from Invitrogen. Anti-EGFR for WB (catalog 06-847) was from Millipore. Anti-p-Ser15-p53 (catalog MAB1839) was from R&D Systems. Anti-ERβ (catalog 06-629) was from Upstate. Anti-tubulin was from Sigma-Aldrich. The tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR), ZD 1839, was from Selleckchem. Bisphenol A (BPA) was from Sigma-Aldrich. The antiandrogen bicalutamide (Casodex) was from Sigma-Aldrich. The antiestrogen ICI 182,780 was from Astra-Zeneca. The MEK-1 inhibitor PD 98,059 was from Sigma-Aldrich. All other reagents were of chemical grade.
+ Open protocol
+ Expand
3

Investigating Kisspeptin Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Kp-10 (Metastin 45-54 (H-YNWNSFGLRF-NH 2 )) of human origin, a Kp form with a potency similar to Xenopus-Kp-10 for bullfrog Gpr54 (Moon et al. 2009) (link), was purchased from DBA Italia, Milan, Italy; Kp-234, a specific Gpr54 antagonist (Roseweir et al. 2009 (link)) was purchased from DBA Italia; 17B-estradiol (E 2 ) was purchased from Sigma-Aldrich S.R.L.; ICI 182780, a high-affinity estrogen receptor antagonist, was purchased from AstraZeneca, UK; and buserelin, a GnRH agonist, was a gift from Dr J Sandow, Hoechst, Frankfurt, Germany.
For Western blot and immunohistochemistry the following antibodies were used: goat polyclonal anti-Kiss-1 antibody (raised against a peptide mapping at the C-terminus of Kiss-1 of human origin; sc-18134) and rabbit polyclonal anti-Gpr54 antibody (raised against amino acids 141-342 mapping within an internal region of Gpr54 of human origin sharing 78% similarity with P. esculentus Gpr54; sc-134499); both were purchased from Santa Cruz Biotechnology and were validated for Western blot and immunohistochemistry (present data, Supplementary Figs 1 and2, see section on supplementary data given at the end of this article; Hsu et al. 2014 (link), Ciaramella et al. 2016) . Mouse monoclonal anti-α-tubulin (T6199) was purchased from Sigma-Aldrich.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!